203 related articles for article (PubMed ID: 27965462)
21. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
22. In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.
Niesen J; Brehm H; Stein C; Berges N; Pardo A; Fischer R; Ten Haaf A; Gattenlöhner S; Tur MK; Barth S
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1049-61. PubMed ID: 25433506
[TBL] [Abstract][Full Text] [Related]
23. OTUD7B Activates Wnt Signaling Pathway through the Interaction with LEF1.
Lee Y; Piao HL; Kim J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371581
[TBL] [Abstract][Full Text] [Related]
24. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.
Zhang M; Truscott J; Davie J
Mol Cancer; 2013 Nov; 12(1):150. PubMed ID: 24279793
[TBL] [Abstract][Full Text] [Related]
25. miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma.
Diao Y; Guo X; Jiang L; Wang G; Zhang C; Wan J; Jin Y; Wu Z
J Biol Chem; 2014 Jan; 289(1):529-39. PubMed ID: 24247238
[TBL] [Abstract][Full Text] [Related]
26. Lef1 is required for the transition of Wnt signaling from mesenchymal to epithelial cells in the mouse embryonic mammary gland.
Boras-Granic K; Chang H; Grosschedl R; Hamel PA
Dev Biol; 2006 Jul; 295(1):219-31. PubMed ID: 16678815
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of impaired differentiation in rhabdomyosarcoma.
Keller C; Guttridge DC
FEBS J; 2013 Sep; 280(17):4323-34. PubMed ID: 23822136
[TBL] [Abstract][Full Text] [Related]
28. Sp5 and Sp8 recruit β-catenin and Tcf1-Lef1 to select enhancers to activate Wnt target gene transcription.
Kennedy MW; Chalamalasetty RB; Thomas S; Garriock RJ; Jailwala P; Yamaguchi TP
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3545-50. PubMed ID: 26969725
[TBL] [Abstract][Full Text] [Related]
29. The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.
Basma H; Ghayad SE; Rammal G; Mancinelli A; Harajly M; Ghamloush F; Dweik L; El-Eit R; Zalzali H; Rabeh W; Pisano C; Darwiche N; Saab R
Int J Cancer; 2016 Mar; 138(6):1528-37. PubMed ID: 26453552
[TBL] [Abstract][Full Text] [Related]
30. beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes.
Zhang CG; Jia ZQ; Li BH; Zhang H; Liu YN; Chen P; Ma KT; Zhou CY
Biochem Biophys Res Commun; 2009 Dec; 390(2):258-62. PubMed ID: 19799869
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of Snail1 transcription factor and Snail1-related genes in alveolar and embryonal rhabdomyosarcoma subtypes.
Püsküllüoglu M; Lukasiewicz E; Miekus K; Jarocha D; Majka M
Folia Histochem Cytobiol; 2010 Dec; 48(4):671-7. PubMed ID: 21478114
[TBL] [Abstract][Full Text] [Related]
32. Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines.
Giannattasio S; Megiorni F; Di Nisio V; Del Fattore A; Fontanella R; Camero S; Antinozzi C; Festuccia C; Gravina GL; Cecconi S; Dominici C; Di Luigi L; Ciccarelli C; De Cesaris P; Riccioli A; Zani BM; Lenzi A; Pestell RG; Filippini A; Crescioli C; Tombolini V; Marampon F
J Endocrinol Invest; 2019 Feb; 42(2):183-197. PubMed ID: 29790086
[TBL] [Abstract][Full Text] [Related]
33. The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.
Kovacs D; Migliano E; Muscardin L; Silipo V; Catricalà C; Picardo M; Bellei B
Oncotarget; 2016 Jul; 7(28):43295-43314. PubMed ID: 27175588
[TBL] [Abstract][Full Text] [Related]
34. Variation in cadherins and catenins expression is linked to both proliferation and transformation of Rhabdomyosarcoma.
Charrasse S; Comunale F; Gilbert E; Delattre O; Gauthier-Rouvière C
Oncogene; 2004 Mar; 23(13):2420-30. PubMed ID: 14691446
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo.
Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Liao ZJ; Yao JT; Li DF; Wang SH; Nan KJ
PLoS One; 2013; 8(10):e76596. PubMed ID: 24098538
[TBL] [Abstract][Full Text] [Related]
36. Proteomic Profiling of Rhabdomyosarcoma-Derived Exosomes Yield Insights into Their Functional Role in Paracrine Signaling.
Rammal G; Fahs A; Kobeissy F; Mechref Y; Zhao J; Zhu R; Diab-Assaf M; Saab R; Ghayad SE
J Proteome Res; 2019 Oct; 18(10):3567-3579. PubMed ID: 31448612
[TBL] [Abstract][Full Text] [Related]
37. Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries.
Schaaf GJ; Ruijter JM; van Ruissen F; Zwijnenburg DA; Waaijer R; Valentijn LJ; Benit-Deekman J; van Kampen AH; Baas F; Kool M
FASEB J; 2005 Mar; 19(3):404-6. PubMed ID: 15629888
[TBL] [Abstract][Full Text] [Related]
38. Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors.
de Souza RR; Oliveira ID; Caran EM; Alves MT; Abib S; Toledo SR
Growth Horm IGF Res; 2012 Dec; 22(6):245-9. PubMed ID: 23079386
[TBL] [Abstract][Full Text] [Related]
39. Lymphoid enhancer factor-1 mediates loading of Pax3 to a promoter harbouring lymphoid enhancer factor-1 binding sites resulting in enhancement of transcription.
Christova T; Mojtahedi G; Hamel PA
Int J Biochem Cell Biol; 2010 May; 42(5):630-40. PubMed ID: 20006729
[TBL] [Abstract][Full Text] [Related]
40. Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching.
Eichhoff OM; Weeraratna A; Zipser MC; Denat L; Widmer DS; Xu M; Kriegl L; Kirchner T; Larue L; Dummer R; Hoek KS
Pigment Cell Melanoma Res; 2011 Aug; 24(4):631-42. PubMed ID: 21599871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
